Filter Results
:
(615)
Show Results For
-
All HBS Web
(615)
- People (4)
- News (99)
- Research (414)
- Events (3)
- Multimedia (4)
- Faculty Publications (248)
Show Results For
-
All HBS Web
(615)
- People (4)
- News (99)
- Research (414)
- Events (3)
- Multimedia (4)
- Faculty Publications (248)
- 18 Dec 2012
- First Look
First Look: December 18
pharmaceutical company GSK must choose how much to integrate a recently acquired biotechnology firm, Sirtris. Moncef Slaoui, GSK's global head of R&D, championed the acquisition of Sirtris to gain access...
View Details
Keywords:
Carmen Nobel
- 18 Aug 2011
- Lessons from the Classroom
Business Plan Contest: 15 Years of Building Better Entrepreneurs
impact on our trajectory." Last year, with three remaining locations in the Boston area, Finale's original lead investors acquired a majority ownership in the business, folding it into a Rhode Island-based holding company where Conforti...
View Details
- 01 Jun 2011
- News
The Best-Laid Plans
Finale’s original lead investors acquired a majority ownership in the business, folding it into a Rhode Island–based holding company where Conforti now serves as managing partner of the restaurant group. “When I started Finale, I...
View Details
- 12 Oct 2006
- First Look
First Look: October 12, 2006
Protection Agency (US EPA) program that encourages companies to self-disclose violations of environmental laws and regulations in exchange for reduced sanctions. We find that facilities are more likely to self-disclose if they were...
View Details
Keywords:
Sean Silverthorne
- 20 Feb 2018
- First Look
First Look at New Research and Ideas, February 20, 2018
new fund. Purchase this case: https://cb.hbsp.harvard.edu/cbmp/product/317036-PDF-ENG Harvard Business School Case 118-052 Charity or Bribery? Filip Kowalski, a senior manager at the pharmaceutical company...
View Details
Keywords:
Sean Silverthorne
- 03 Jan 2017
- First Look
January 3, 2017
silos within numerous academic medical centers, pharmaceutical companies, and some disease-based foundations. For new precision therapies to be developed, these data sets need to be shared broadly. Patients can help lead this effort by...
View Details
Keywords:
Carmen Nobel
- 10 Jan 2005
- Research & Ideas
Motivation and the Cross-Sector Alliance
The first question focuses on motivations, while the second one has more to do with the benefits sought in interactions with future partners. Altruism As a general rule, collaboration efforts between companies and CSOs have an inherent...
View Details
- 28 May 2008
- First Look
First Look: May 28, 2008
goals? Purchase the case: http://www.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=308030 Can PACIV (Puerto Rico) Serve European Customers? Harvard Business School Case 808-099 Jorge Rodriguez-Gonzalez, PACIV's (Puerto Rico) founding CEO, is considering expanding...
View Details
Keywords:
Martha Lagace
- 24 Feb 2009
- First Look
First Look: February 24, 2009
http://www.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=909036 Esser & Ackermann at Mannesmann Harvard Business School Case 209-095 No abstract is available at this time. Purchase this case:...
View Details
Keywords:
Martha Lagace
- 01 Dec 2001
- News
Reaching Out
Ph.D. in pathology and molecular biology at Boston University's School of Medicine. Intrigued by his experience with pharmaceutical companies and the role of business in drug delivery, he enrolled at HBS one...
View Details
- 01 Dec 2010
- News
This Is What I Do
thus deserve our support.” The MJFF raises about $50 million a year. There are prominent backers, such as Google’s Sergey Brin and his wife, Anne Wojcicki, but nearly 55,000 other people made contributions last year. To date the MJFF has supported about ninety biotech...
View Details
- 03 Sep 2013
- First Look
First Look: September 3
results. Purchase this case: http://hbr.org/search/713537-PDF-ENG Harvard Business School Case 814-014 Sample6: Innovating to Make Food Safer Tim Curran, CEO of Sample6, a start-up biotechnology company developing a novel food safety...
View Details
Keywords:
Sean Silverthorne
- 03 Nov 2015
- First Look
November 3, 2015
quantify the impact of scientific grant funding at the National Institutes of Health (NIH) on patenting by pharmaceutical and biotechnology firms. Our paper makes two contributions. First, we use newly constructed bibliometric data to...
View Details
Keywords:
Sean Silverthorne
- 02 Aug 2018
- News
Can Marketing Help Halt the Heroin Epidemic?
going to take care of themselves, meaning prescriber limits are coming down, the way that doctors are prescribing is changing, CDC have got guidelines, lawsuits against these pharmaceutical companies and the...
View Details
- 01 Dec 2008
- News
A Force for Good
that he can see around corners,” Connors adds. “He is a wise man who can see the future — whether it was with the railroads, or whether it was with the hospitals, or whether it was with many companies that he was involved with, or whether...
View Details
- 12 Jul 2021
- News
Alumni Confront the COVID-19 Crisis
the availability of critical resources, and the efficacy of both pharmaceutical and non-pharmaceutical interventions. The company has created a set of free publicly available visual analytic dashboards. "The...
View Details
- 19 Jan 2023
- News
Forged in Fire
empathy, particularly for their employees. And I would say the toughest one to have is courage. Now Chad has to have courage, but I've seen a lot of CEOs that have no courage and their companies don't fare well over time. Now, the...
View Details
- Web
Print View - Course Catalog
lined up to fund over 500 startups that use Generative AI. CEO’s of some of the leading AI companies have gone on record to say that this generation of AI could destroy human society. Others have said that it could create a global utopia...
View Details